Oura secured $75 million in funding led by Dexcom, increasing its valuation to $5.2 billion and paving the way for enhanced health tracking capabilities in wearables.
Target Information
Oura is an innovative health technology company that is transforming wellness through its state-of-the-art wearable rings. These advanced devices integrate seamless health tracking with a stylish and minimalist design, offering users the tools they need to optimize their overall well-being. The Oura Ring is designed to deliver comprehensive insights into various health metrics, including sleep quality, physical activity, and general health status.
Equipped with sophisticated sensors, the Oura Ring monitors essential metrics such as heart rate, heart rate variability, body temperature, and blood oxygen levels. By providing users with actionable data, the Oura Ring helps enhance both daily performance and long-term health.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Finland
Finland has emerged as a leader in health technology, characterized by a robust ecosystem that fosters innovation and collaboration between startups, research institutions, and established corporations. Th
Similar Deals
Hammas Hohde Oy → Hammasklinikka Kruunu Oy
2025
PlusTerveys Hammasklinikat Oy → Hyggan klinikkaliiketoiminta
2025
Dexcom
invested in
Oura
in 2022
in a Other deal
Disclosed details
Transaction Size: $75M
Enterprise Value: $5,200M